HPLC and mass spectrometry: what each test actually proves

Two questions, two instruments

RP-HPLC answers a quantitative question: of the material that absorbs at the detection wavelength, what fraction elutes as a single peak at the expected retention time. Mass spectrometry answers a qualitative one: is the molecule present the molecule specified.

Neither substitutes for the other. A sample can be 99.5% pure by HPLC and be the wrong peptide entirely — purity says nothing about identity. Equally, a mass spectrum can confirm the correct molecular weight in a sample that is 60% related substances, because MS detects presence rather than proportion.

Reading a chromatogram properly

The number quoted as purity is the area of the main peak divided by the total integrated area, expressed as a percentage. That makes the integration baseline consequential: a baseline drawn generously under a shoulder can move a 96% result to 98.5% without any change to the material.

This is why the trace itself matters more than the number. Look for a symmetric main peak, a flat baseline, and whether close-eluting shoulders have been integrated separately or absorbed into the main peak. Detection is typically at 214 nm, which sees the amide bond and therefore all peptide-related species; 280 nm sees only aromatic residues and will under-report impurities lacking them.

What the mass result should show

The reported observed mass should match the theoretical monoisotopic or average mass within the instrument's stated tolerance — typically well under 1 Da for a peptide of this size on a modern instrument. Larger deviations warrant explanation.

Characteristic offsets are diagnostic. A result 18 Da low suggests dehydration or an unintended cyclisation; 42 Da high suggests residual acetylation; 16 Da high suggests methionine oxidation. A supplier that reports only 'MS confirmed' without the observed value has removed the only part of the result you could have checked.

What a certificate still does not tell you

Neither analysis addresses endotoxin, bioburden, residual solvents, or heavy metals. Neither establishes potency in a biological system. And crucially, neither carries forward in time: a certificate documents the material as it was at release, not as it is after nine months in a warm cupboard.

Treat the certificate as a release record with a date attached. For long-held stock in quantitative work, periodic re-assay is the only way to know the current state of the material.

Two questions, two instruments

HPLC answers how much of the sample is one thing. Mass spectrometry answers what that thing is. The distinction is not academic: a sample can be 99 percent pure and be 99 percent of the wrong peptide, and only mass confirmation excludes that. Conversely a correct mass tells you the intended molecule is present but nothing about what shares the vial with it.

In practice the two are run in sequence and sometimes in tandem. Analytical reversed-phase HPLC separates the sample by hydrophobicity and integrates the resulting peaks; electrospray mass spectrometry ionises the eluate and reports mass-to-charge ratios from which the neutral mass is deconvoluted. LC-MS combines them so that each chromatographic peak carries its own mass assignment — which is how an impurity is identified as a specific deletion sequence rather than merely counted.

A complete release package therefore contains both, plus the chromatogram itself. The chromatogram matters because peak shape and baseline behaviour carry information the summary percentage discards, including co-elution that inflates the purity figure.

Reading mass results against theory

The comparison is between observed monoisotopic or average mass and the theoretical mass of the specified sequence in the specified form. Agreement within a small tolerance confirms sequence length, terminal modification state and any intramolecular bridges.

Characteristic deviations are diagnostic. Sixteen daltons high indicates oxidation, most often at methionine. Two daltons low indicates disulfide bond formation where a reduced form was expected. Mass differences matching a single residue point to deletion sequences from incomplete coupling during synthesis. Forty-two daltons high can indicate acetylation, whether intended or from capping during synthesis.

What mass spectrometry cannot resolve is stereochemistry or, in most routine methods, the difference between isobaric residues. Racemisation during synthesis produces a diastereomer with an identical mass; it is a chromatographic problem, resolved by the HPLC method, which is another reason the two techniques are complementary rather than alternatives.

What each technique answers

The two are complementary, not alternatives. Each excludes a failure the other cannot see.